EASDnet: Empowering human-centered evidence-based medicine through an evidence and attention-based spatial disparity network for discriminative colorectal cancer histopathological screening and attribution.
2/5 보강
TL;DR
The pathological diagnostic capabilities of EASDnet are superior to the current state-of-the-art methods for determining colorectal cancer status and is a promising and valuable learning model that can advance objective diagnostic strategies and improve clinical care for patients with colorectal cancer.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: colorectal cancer
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Therefore, an objective, evidence-based quantitative analysis tool is essential to assist clinicians. This study introduces and validates an evidence-based medicine (EBM) deep learning model that addresses these limitations by providing reliable, automated pathological screening from medical images.
OpenAlex 토픽 ·
AI in cancer detection
Machine Learning in Healthcare
Colorectal Cancer Screening and Detection
The pathological diagnostic capabilities of EASDnet are superior to the current state-of-the-art methods for determining colorectal cancer status and is a promising and valuable learning model that ca
APA
Siming Zheng, shaowen bi (2026). EASDnet: Empowering human-centered evidence-based medicine through an evidence and attention-based spatial disparity network for discriminative colorectal cancer histopathological screening and attribution.. Pathology, research and practice, 281, 156418. https://doi.org/10.1016/j.prp.2026.156418
MLA
Siming Zheng, et al.. "EASDnet: Empowering human-centered evidence-based medicine through an evidence and attention-based spatial disparity network for discriminative colorectal cancer histopathological screening and attribution.." Pathology, research and practice, vol. 281, 2026, pp. 156418.
PMID
41764810 ↗
Abstract 한글 요약
[PURPOSE] Accurate preoperative staging of colorectal cancer is critical to guide treatment decisions, including eligibility for R0 resection, to reduce recurrence and improve patient survival. However, conventional imaging evaluation depends on human experience, leading to subjectivity and diagnostic uncertainty in clinical interpretation. Therefore, an objective, evidence-based quantitative analysis tool is essential to assist clinicians. This study introduces and validates an evidence-based medicine (EBM) deep learning model that addresses these limitations by providing reliable, automated pathological screening from medical images.
[METHODS] We formulate the novel EASDnet model, an EBM-based deep learning architecture for the discriminative screening of colorectal cancer lesions, which incorporates an evidence and attention-based mechanism to learn subtle morphological differences between cancerous lesions and their surrounding microenvironment. This approach effectively captures inter-class and intra-class discriminative and differentiating features from histopathological data.
[RESULTS] EASDnet is rigorously trained and validated using publicly available image datasets, NCT-100K and LC25000. The proposed model demonstrated robust performance in quantitative colorectal cancer diagnosis. Evaluating EASDnet on the respective datasets confirmed its high discriminative capability, with accuracy scores of 97.76% and 98.52%.
[CONCLUSION] The pathological diagnostic capabilities of EASDnet are superior to the current state-of-the-art methods for determining colorectal cancer status. With its optimized performance in tissue dividing and feature inference, EASDnet is a promising and valuable learning model that can advance objective diagnostic strategies and improve clinical care for patients with colorectal cancer.
[METHODS] We formulate the novel EASDnet model, an EBM-based deep learning architecture for the discriminative screening of colorectal cancer lesions, which incorporates an evidence and attention-based mechanism to learn subtle morphological differences between cancerous lesions and their surrounding microenvironment. This approach effectively captures inter-class and intra-class discriminative and differentiating features from histopathological data.
[RESULTS] EASDnet is rigorously trained and validated using publicly available image datasets, NCT-100K and LC25000. The proposed model demonstrated robust performance in quantitative colorectal cancer diagnosis. Evaluating EASDnet on the respective datasets confirmed its high discriminative capability, with accuracy scores of 97.76% and 98.52%.
[CONCLUSION] The pathological diagnostic capabilities of EASDnet are superior to the current state-of-the-art methods for determining colorectal cancer status. With its optimized performance in tissue dividing and feature inference, EASDnet is a promising and valuable learning model that can advance objective diagnostic strategies and improve clinical care for patients with colorectal cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Temporal radiomics for non-invasive preoperative prediction of pathologic complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
- CAR immune cell therapy strategies and advances for lung cancer.
- Chromosomal instability promotes cell migration and invasion via EFEMP1 secretion into extracellular vesicles.
- Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
- Dissector-Assisted Liposuction for Dorsocervical Fibrolipodystrophy (Buffalo Hump): Results from 57 Patients.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.